4.5 Article

Generalizability of heterogeneous treatment effects based on causal forests applied to two randomized clinical trials of intensive glycemic control

Journal

ANNALS OF EPIDEMIOLOGY
Volume 65, Issue -, Pages 101-108

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.annepidem.2021.07.003

Keywords

Generalizability; Glycemic control; Heterogeneous treatment effects; Causal forests

Funding

  1. US Department of Veterans Affairs [IK2-CX001907, 465-F, 2008]
  2. American Heart Association [17MCPRP33670728]
  3. National Science Foundation [DMS 1914937]
  4. National Cancer Institute of the US National Institutes of Health [R01 CA129102]
  5. National Institute of Diabetes and Digestive and Kidney Diseases of the US National Institutes of Health [K23DK109200]
  6. Veterans Affairs Cooperative Studies Program, Department of Veterans Affairs Office of Research and Development
  7. American Diabetes Association
  8. National Eye Institute
  9. Sanofi
  10. GlaxoSmithKline
  11. Novo Nordisk
  12. Roche
  13. Kos Pharmaceuticals
  14. Merck
  15. Amylin

Ask authors/readers for more resources

The generalizability of heterogeneous treatment effects (HTE) derived from machine learning in different study samples is uncertain. In this study, the authors examined the generalizability of HTE detected using causal forests in two randomized trials in type II diabetes patients. They found that while the variable importance was correlated between the two trials, the HTE did not replicate in similar subgroups, suggesting limited generalizability.
Purpose Machine learning is an attractive tool for identifying heterogeneous treatment effects (HTE) of interventions but generalizability of machine learning derived HTE remains unclear. We examined generalizability of HTE detected using causal forests in two similarly designed randomized trials in type II diabetes patients.Methods We evaluated published HTE of intensive versus standard glycemic control on all-cause mortality from the Action to Control Cardiovascular Risk in Diabetes study (ACCORD) in a second trial, the Veterans Affairs Diabetes Trial (VADT). We then applied causal forests to VADT, ACCORD, and pooled data from both studies and compared variable importance and subgroup effects across samples.Results HTE in ACCORD did not replicate in similar subgroups in VADT, but variable importance was correlated between VADT and ACCORD (Kendall's tau-b 0.75). Applying causal forests to pooled individual-level data yielded seven subgroups with similar HTE across both studies, ranging from risk difference of all-cause mortality of-3.9% (95% CI-7.0,-0.8) to 4.7% (95% CI 1.8, 7.5).Conclusions Machine learning detection of HTE subgroups from randomized trials may not generalize across study samples even when variable importance is correlated. Pooling individual-level data may overcome differences in study populations and/or differences in interventions that limit HTE generalizability.Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available